The rising prevalence of Leukemia and Multiple myeloma and the increasing awareness among patients and healthcare professionals about initial diagnosis are driving the demand for the market.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |